[House dust mite allergy: myths and realities]

Christine Bouton1, Julien Ducommun

  • 1Service d'Immunologie et d'allergologie, Département de médecine interne, HUG, 1211 Genève 14. christine.bouton@hcuge.ch

Insights

House dust mites (HDM) like Dermatophagoides pteronyssinus are primary allergens causing allergic diseases such as asthma. This review clarifies the controversial topic of HDM control measures in homes.

Area of Science:

  • Allergology
  • Environmental Health

Background:

  • House dust mites (HDM) are a major cause of allergic diseases globally.
  • Dermatophagoides pteronyssinus and Dermatophagoides farinae are the predominant species found in bedding.
  • HDM allergens trigger conditions like asthma, rhinitis, and atopic dermatitis.

Purpose of the Study:

  • To clarify the current understanding of house dust mite allergy.
  • To address the controversies surrounding house dust mite control measures.
  • To provide an evidence-based perspective on managing HDM allergies.

Main Methods:

  • Review of existing medical literature on house dust mites and allergy.
  • Analysis of studies on the effectiveness of various treatment and control strategies.
  • Discussion of recent debates in the scientific community regarding HDM control.

Main Results:

  • Established treatments like subcutaneous immunotherapy are effective.
  • The efficacy and recommendations for environmental control measures remain debated.
  • Significant presence of HDM found in domestic environments, particularly bedding.

Conclusions:

  • House dust mite allergy remains a significant public health concern.
  • While treatments exist, effective and universally accepted control strategies are still under discussion.
  • Further research and clear guidelines are needed for optimal house dust mite management.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Allergic Reactions02:06

Allergic Reactions

Overview
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...